-
Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care.
dela Cruz AM, Walker NR, Pipes R, Wakhlu S, Trivedi MH. Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care. Addiction Science & Clinical Practice 2021;16:12.
-
Bupropion and naltrexone in methamphetamine use disorder.
Trivedi MH, Walker NR, Ling W, dela Cruz AM, Sharma G, Carmody T, Ghitza UE, Wahle A, Kim M, Shores-Wilson K, Sparenborg S, Coffin P, Schmitz J, Wiest K, Bart G, Sonne SC, Wakhlu S, Rush AJ, Nunes EV, Shoptaw S. Bupropion and naltrexone in methamphetamine use disorder. New England Journal of Medicine 2021;384:140-153.
-
Prevalence and medication treatment of opioid use disorder among primary care patients with hepatitis C and HIV.
Tsui JI, Akosile MA, Lapham GW, Boudreau DM, Johnson EA, Bobb JF, Binswanger IA, Yarborough BJH, Glass JE, Rossom RC, Murphy MT, Cunningham CO, Arnsten JH, Thakral M, Saxon AJ, Merrill JO, Samet JH, Bart GB, Campbell CI, Loree AM, Silva A, Stotts AL, Ahmedani B, Braciszewski JM, Hechter RC, Northrup TF, Horigian VE, Bradley KA. Prevalence and medication treatment of opioid use disorder among primary care patients with hepatitis C and HIV. Journal of General Internal Medicine 2021;36:930-937.
-
Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance use.
Traynor SM, Metsch LR, Gooden LK, Stitzer ML, Matheson T, Tross S, Carrico AW, Jain MK, del Rio C, Feaster DJ. Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance use. Drug and Alcohol Dependence 2021;221:108567.
-
Core Outcomes Set for Research on the Treatment of Opioid Use Disorder (COS-OUD): The National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study.
Karnik NS, Campbell CI, Curtis ME, Fiellin DA, Ghitza UE, Hefner K, Hser Y, McHugh RK, Murphy SM, McPherson SM, Moran L, Mooney LJ, Wu L, Shmueli-Blumberg D, Shulman M, Schwartz RP, Stephens KA, Watkins KE, Marsden J. Core Outcomes Set for Research on the Treatment of Opioid Use Disorder (COS-OUD): The National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study. Addiction Science & Clinical Practice 2021;22:102.
-
An alternative analysis of illicit opioid use during treatment in a randomized trial of extended-release naltrexone versus buprenorphine-naloxone: A per-protocol and completers analysis.
Mitchell MM, Schwartz RP, Choo T, Pavlicova M, O'Grady KE, Gryczynski J, Stitzer ML, Nunes EV, Rotrosen J. An alternative analysis of illicit opioid use during treatment in a randomized trial of extended-release naltrexone versus buprenorphine-naloxone: A per-protocol and completers analysis. Drug and Alcohol Dependence 2021;219:108422
-
PRimary Care Opioid Use Disorders Treatment (PROUD) trial protocol: A pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
Campbell CI, Saxon AJ, Boudreau DM, Wartko PD, Bobb JF, Lee AK, Matthews AG, McCormack J, Liu DS, Addis M, Altschuler A, Samet JH, LaBelle CT, Arnsen J, Caldeiro RM, Borst DT, Stotts AL, Braciszewski JM, Szapocznik J, Bart G, McNeely J, Liebschutz JM, Yarborough BJH, Bradley KA. PRimary Care Opioid Use Disorders Treatment (PROUD) trial protocol: A pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addiction Science & Clinical Practice 2021;16(9).
-
Patients’ perspectives on initiating treatment with extended-release naltrexone (XR-NTX).
Gauthier P, Greco P, Meyers-Ohki S, Desai A, Rotrosen J. Patients' perspectives on initiating treatment with extended-release naltrexone (XR-NTX). Journal of Substance Abuse Treatment 2021;122:108183.
-
Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: Results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.
Wu L, John WS, Ghitza UE, Wahle A, Matthews AG, Lewis M, Hart B, Hubbard Z, Bowlby LA, Greenblatt LH, Manelli P, Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: Results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network. Addiction 2021;116(7):1805-1816.
-
Re-thinking patient stability for methadone in opioid treatment during a global pandemic: Provider perspectives.
Hatch-Maillette MA, Peavy KM, Tsui JI, Banta-Green CJ, Woolworth S, Grekin P. Re-thinking patient stability for methadone in opioid treatment during a global pandemic: Provider perspectives. Journal of Substance Abuse Treatment 2021;124:108223.